BAT H1 FY2026 Trading Update: New Categories Revenue Surges to Mid-Teens Growth — Inside the Vapour, Oral & Heated Tobacco Transformation
Velo double-digit growth, Vuse steady gains, glo bottoming out — a business-level deep dive for distributors eyeing diversified smoke-free sourcing strategies in H2 2026
On June 1, 2026, British American Tobacco (LSE: BATS; NYSE: BTI) released its H1 FY2026 Pre-Close Trading Update, delivering the clearest picture yet of how Big Tobacco’s vapour diversification is performing at scale. For US distributors sourcing smoke-free products from multinational suppliers, BAT’s results reveal a company rapidly transitioning from a declining combustible cigarette business into a multi-category new-tobacco powerhouse.
📈 New Categories revenue growth accelerated to mid-teens — up from previous low-double-digit guidance. Velo (oral), Vuse (vapour), and glo (heated tobacco) are each at different inflection points, creating distinct sourcing windows for American importers.
📋 What BAT Shared — Full-FY Guidance Revisions at a Glance
BAT’s trading update reaffirmed its full-year FY2026 guidance but upgraded growth expectations for new categories (smoke-free products), the segment encompassing Vuse vapour, Velo modern oral tobacco products, and glo heated tobacco. Here are the key figures:
| Metric | FY2026 Guidance (Updated) | Context / YoY Impact of FX |
|---|---|---|
| Total Revenue Growth | 3%–5% | Solid mid-term baseline; stable |
| Adjusted Operating Profit Growth | 4%–6% | H2-weighted delivery (~1% FX tailwind vs H1 |
| New Categories Revenue (Smoke-Free) | ⬆⬆ Mid-Teens Growth ⬆⬆ | ↑ Upgraded from low-teens |
| FY Adjusted Diluted EPS | 5%–8% | 💰 2–3% FX headwind (USD/GBP 1.348) |
| Net Finance Costs | ~$1.75bn | ⬇ Lower than prior $1.8bn estimate |
| Cash Conversion Rate | >95% | Robust operational execution |
⚠️ The single most significant signal for distributors: BAT upgraded its new categories growth expectation. This is not a minor tweak — it represents accelerating demand for smoke-free products across BAT’s global portfolio, with vapour (Vuse/Vype) contributing materially to that acceleration.
💡 Vapour & E-cigarette: Vuse Drives Mid-Single Digit Growth, Premium Segment Win
BAT’s vapour division — encompassing Vuse (global) and the earlier Vype brand in select markets — grew revenues at a mid-single digit rate in H1 2026 and is on track for similar growth for the full fiscal year. For US distributors, this metric masks some structurally significant developments:
🇺🇸 United States: The Primary Engine (⬆ +4.2 pts Value Share)
The US market delivered the strongest vapour performance across all BAT regions:
- Vuse Ultra — BAT’s premium pod system, launched in late H2 2025, drove meaningful revenue contribution in Q1-Q2 FY2026. Premium pricing (USD $9.99+ per device) generated disproportionate profit growth even at modest volume.
- Value Share +4.2 pts — BAT’s Vuse captured 4.2 percentage points of core-channel vapour market share value, outpacing the broader US single-use pod category decline as consumers upgraded from disposables to rechargeable pods.
- E-cigarette repositioning — With FDA PMTA submissions advancing for several Vuse refill flavors, BAT is strategically shifting marketing messaging from “disposable” to “long-lasting sustainable vaping.”
🌍 Europe / AMPA: Regulatory Headwinds Offset By Premium Product Mix
European vapour revenue growth was partially moderated by new nicotine solutions regulations in the UK and Poland, combined with national single-use vape bans cascading across the EU. However, BAT’s premium product mix (Vuse Velo-compatible pods at EUR €5–7 per refill) kept overall share erosion manageable.
👩💼 Modern Oral: Velo’s Explosive Double-Digit Growth Is the Dark Horse
While vapour gets most of the headlines, BAT’s Velo modern oral tobacco (moist pouch) division delivered double-digit revenue growth in H1 FY2026 and is likely accelerating — not slowing:
- 🇺🇸 US Velo Plus market share +10.4 pts: In a single core state, Velo captured over 10 additional percentage points of total oral nicotine category share in the first half of FY2026.
- 🌍 Global Modern Oral Share +7.4 pts — Out-indexing the overall smoke-free oral product market by wide margins, indicating strong consumer habit-formation around moisture pouches vs dry snuff and traditional nicotine gum.
- AME Region: Category Leader — Across Asia-Middle East-Africa regions, Velo continues to hold global category leadership with value share growth well above industry averages.
— BAT H1 FY2026 Pre-Close Trading Update, June 2, 2026
🔥 For distributors sourcing from BAT’s portfolio: The combination of Vuse vapour + Velo oral products creates a “dual smoke-free” sourcing opportunity — US importers can offer customers both inhalable and non-combustible nicotine delivery systems from one diversified supplier, reducing supply chain concentration risk.
🔥 Heated Tobacco: glo Is Bottoming, Q2 Share Recovery Underway
BAT’s heated tobacco division (glo) faced H1 headwinds from inventory liquidation in Japan and aggressive low-price competition across Asia-Pacific. Revenue grew at a lower rate but the quality share shift indicates glo is stabilizing:
- glo Hilo Premium Segment: Japan (2.6% share), Poland (8.8%), Italy (1.5%) — premium devices are gaining traction in developed markets where consumers upgrade from base-level heated tobacco units.
- New Launches: glo Hyper Pro Plus launched in Italy, Romania, Greece — mid-tier pricing to compete with Chinese-sourced equivalents while capturing upgraded buyers leaving the disposable vapour category.
📊 Strategic Playbook: What US Distributors Should Source in H2 2026
Based on BAT’s operational data, here are three actionable sourcing strategies for Q3-Q4 2026:
🎯 Strategy Ⅰ: Premium Vuse Pod Portfolio (High Margin)
Priority product: Vuse Ultra pre-filled pod refills targeting US core-channel retail. These command premium pricing that keeps margins healthy even as disposable unit volumes decline industry-wide.
📥 Strategy Ⅱ: Velo Moist Pouch Diversification
Priority product: Velo Plus and emerging international SKUs. The non-combusted oral nicotine market is expanding rapidly — importers who establish relationships now will lock in early pricing before Chinese alternatives capture scale.
🔄 Strategy Ⅲ: glo for International Expansion
Priority product: glo Hyper Pro Plus (mid-tier) and glo Hilo (premium). As EU single-use vape bans take effect, heated tobacco represents a bridge category for consumers transitioning from combustible cigarettes who aren’t ready for vapour.
📖 Final Takeaway: BAT Is No Longer “Just Tobacco” — It’s a New Categories Company
👎
BAT H1 FY2026 data proves the diversification thesis is working at scale: New categories revenue growing at mid-teens rates while overall tobacco revenues grow at single digits. Vapour remains the cornerstone business (Vuse/Vype), but modern oral nicotine products (Velo) and heated tobacco (glo) are creating a diversified smoke-free portfolio that US distributors can source from as a single supplier.
The takeaway for American importers: Don’t bet everything on disposable vapour anymore. The Vuse Ultra premium pod + Velo oral product combination represents the highest-margin, most sustainable sourcing strategy for H2 2026 and beyond — as BAT’s own financials confirm.
✏️ Published by GBA USA Editorial — Independent Vape & E-Cigarette Industry Intelligence. For distributor sourcing insights, follow our daily analysis.